Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corteva (CTVA) Current Deferred Revenue (2020 - 2025)

Corteva has reported Current Deferred Revenue over the past 6 years, most recently at $3.6 billion for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 8.88% year-over-year to $3.6 billion; the TTM value through Dec 2025 reached $3.6 billion, up 8.88%, while the annual FY2025 figure was $3.6 billion, 8.88% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $3.6 billion at Corteva, up from $483.0 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $3.6 billion in Q4 2025 and troughed at $358.0 million in Q2 2025.
  • A 5-year average of $1.8 billion and a median of $1.6 billion in 2021 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: surged 73.55% in 2021 and later plummeted 37.04% in 2024.
  • Year by year, Current Deferred Revenue stood at $3.2 billion in 2021, then increased by 5.84% to $3.4 billion in 2022, then grew by 0.53% to $3.4 billion in 2023, then decreased by 3.49% to $3.3 billion in 2024, then grew by 8.88% to $3.6 billion in 2025.
  • Business Quant data shows Current Deferred Revenue for CTVA at $3.6 billion in Q4 2025, $483.0 million in Q3 2025, and $358.0 million in Q2 2025.